Real-world evidence for neovascular age-related macular degeneration : a practical approach
| Errataetall: |
CommentOn: Ophthalmology. 2015 Dec;122(12):2514-22. - PMID 26391465 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Eye (London, England) - 37(2023), 1 vom: 05. Jan., Seite 1-3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Teo, Kelvin Yi Chong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Angiogenesis Inhibitors |
|---|
| Anmerkungen: |
Date Completed 11.01.2023 Date Revised 02.01.2024 published: Print-Electronic CommentOn: Ophthalmology. 2015 Dec;122(12):2514-22. - PMID 26391465 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41433-022-02151-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343245310 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343245310 | ||
| 003 | DE-627 | ||
| 005 | 20240108140609.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41433-022-02151-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1246.xml |
| 035 | |a (DE-627)NLM343245310 | ||
| 035 | |a (NLM)35804018 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Teo, Kelvin Yi Chong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world evidence for neovascular age-related macular degeneration |b a practical approach |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2023 | ||
| 500 | |a Date Revised 02.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ophthalmology. 2015 Dec;122(12):2514-22. - PMID 26391465 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Angiogenesis Inhibitors |2 NLM | |
| 650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
| 650 | 7 | |a Ranibizumab |2 NLM | |
| 650 | 7 | |a ZL1R02VT79 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Eye (London, England) |d 1995 |g 37(2023), 1 vom: 05. Jan., Seite 1-3 |w (DE-627)NLM012628646 |x 1476-5454 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:1 |g day:05 |g month:01 |g pages:1-3 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41433-022-02151-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2023 |e 1 |b 05 |c 01 |h 1-3 | ||